Fumiaki Ikeno, MD

Researcher
Stanford University
Stanford, California, United States

Dr. Ikeno is a Research Associate, Cardiovascular Medicine, Stanford University. In this role, he is responsible for pre clinical studies including GLP for medical devices and also regenerative medicines for cardiovascular diseases. Currently, he is devoting himself to the international regulatory project between Japan and the United States, also known as "Harmonization by Doing", whose focus is to collaborate with regulatory agencies such as FDA, PMDA/MHLW, academia and industries for improving the regulatory process in the 2 largest medtech markets. He serves as the Program Director (US) for Japan Biodesign.

Presentation(s):

• Panel Discussion – How Can These Experiences Inform Future Global Clinical and Regulatory Strategies?

  Sunday, February 26, 2023
  9:30 AM – 10:15 AM ET

  Disclosure information not submitted.

• DIGITAL HEALTH AND ARTIFICIAL INTELLIGENCE

  Monday, February 27, 2023
  10:30 AM – 12:00 PM ET

  Disclosure information not submitted.

• Panel discussion – What are the Potential Barriers to Multinational Regulation of Novel Digital Health Products and How can we Address Them?

  Monday, February 27, 2023
  11:15 AM – 11:50 AM ET

  Disclosure information not submitted.